24
Participants
Start Date
July 10, 2025
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
Y-3 for injection(40mg)
"The investigational drug (Y-3) consists of two parts: Y-3 for injection (lyophilized powder) and Solvent for Y-3 for injection (concentrated solution).~Name: Y-3 for injection Strength: 20 mg Dosage Form: Lyophilized powder for injection Storage Condition: 2-8°C Supplier: Neurodawn Pharmaceutical Co., Ltd. Name: Reconstitution diluent for Y-3 for injection Strength: 3ml (containing 0.6 g propylene glycol) Dosage Form: Concentrated solution for injection Storage Condition: 2-8°C Supplier: Neurodawn Pharmaceutical Co., Ltd."
Lead Sponsor
Neurodawn Pharmaceutical Co., Ltd.
INDUSTRY